Trial of VivaGel in Sexually Active Young Women Commences
Starpharma Holdings Limited announced the commencement in the U.S. of a trial to assess the safety and acceptability of SPL7013 Gel (VivaGel(TM)) in sexually active young women.
The Microbicide Trials Network (MTN) is leading the study, funded by the U.S. National Institutes of Health (NIH)...
Starpharma Develops New Gel (Vivagel) To Prevent HIV Transmission
...l company Starpharma saw an 8% increase in its share, following approval of vivagel
by the FDA, a new formulation, believed to prevent transmission of HIV. // ...ts for the prevention of HIV infection. The FDA recognizes the potential of vivagel
to address this unmet medical need. Vivagel's new drug application will now...